Form CORRESP - Correspondence:
SEC Accession No. 0001193125-25-002854
Filing Date
2025-01-07
Accepted
2025-01-07 16:16:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 12383
2 GRAPHIC g769642g21j92.jpg GRAPHIC 2841
  Complete submission text file 0001193125-25-002854.txt   17423
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)